URI
46
3
MCO
68
4
CA
13
-6
CB
55
11
FITB
62
3
IVZ
43
4
EOG
42
4
EQIX
57
4
DOV
64
5
UNP
32
2
NRG
69
17
MA
64
2
PRU
64
4
PNW
67
-3
V
50
4
XYL
33
2
CME
59
-2
FAST
45
5
AIZ
75
2
JBHT
40
5
URI
46
3
MCO
68
4
CA
13
-6
CB
55
11
FITB
62
3
IVZ
43
4
EOG
42
4
EQIX
57
4
DOV
64
5
UNP
32
2
NRG
69
17
MA
64
2
PRU
64
4
PNW
67
-3
V
50
4
XYL
33
2
CME
59
-2
FAST
45
5
AIZ
75
2
JBHT
40
5
Financhill
Back

Gevo Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
37

GEVO
Gevo

Last Price:
$1.26
Seasonality Move:
-7.85%
Buy
52

SRPT
Sarepta Therapeutics

Last Price:
$73.63
Seasonality Move:
14.66%
Sell
37
Gevo (GEVO) is a Sell

Is Gevo a Buy, Sell or Hold?

  • The current Gevo [GEVO] share price is $1.30. The Score for GEVO is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • GEVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $76.33. The Score for SRPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GEVO Stock Price Chart

What is Gevo's stock price today?

  • The Gevo share price today is $1.30
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GEVO is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $76.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

GEVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 41.22 Sell
Chaikin Money Flow: -430238 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.23 - 1.57) Sell
Bollinger Bands (100): (1.34 - 2.18) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.07 Sell
Relative Strength Index (14 RSI): 30.8 Sell
Chaikin Money Flow: 1304026 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (86.54 - 110.54) Sell
Bollinger Bands (100): (102.23 - 127.85) Sell

GEVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.31 Sell
20-day SMA: 1.33 Sell
50-day SMA: 1.68 Sell
200-day SMA: 1.37 Sell
8-day EMA: 1.31 Sell
20-day EMA: 1.38 Sell
50-day EMA: 1.55 Sell
200-day EMA: 1.48 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.29 Sell
20-day SMA: 96.26 Sell
50-day SMA: 107.61 Sell
200-day SMA: 124.92 Sell
8-day EMA: 82.75 Sell
20-day EMA: 92.99 Sell
50-day EMA: 104.03 Sell
200-day EMA: 117.97 Sell

Gevo Earnings Growth & GEVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.06 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.

Gevo Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):